Home Your basket
• Speech disorders, verbal ...
   Price 10.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Predictive factors for su...
   Price 15.00 €
• Moderate leukocyte infilt...
   Price 10.50 €
• The effects of passive sm...
   Price 10.50 €
• Endovascular treatment of...
   Price 12.00 €
• Social consequence of a d...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Somatic tinnitus (review)...
   Price 12.50 €
• Speech intelligibility in...
   Price 10.50 €
• Is it possible to evolve ...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• A rare tumor of the parap...
   Price 5.50 €
• The «intra-cordal polyp»:...
   Price 5.50 €
• A study of the effects of...
   Price 14.00 €
• Management of cerebellopo...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 5.50 €
• Congenital cyst and fistu...
   Price 10.50 €
• Description of complicati...
   Price 5.50 €
• Validity of cervical ausc...
   Price 12.00 €
• Reconstruction of bone de...
   Price 10.50 €
• The role of larynx kinest...
   Price 10.50 €
• An unusual cause of neona...
   Price 5.50 €
• Comparison of radical (na...
   Price 10.50 €
• Side-to-end hypoglossal-f...
   Price 10.50 €
• Videonystagmography and v...
   Price 10.50 €
• Epistaxis and hospitalisa...
   Price 10.50 €
• New potentialities of the...
   Price 12.50 €
• Laryngeal papillomatosis ...
   Price 5.50 €
• The relevance of Choukrou...
   Price 10.50 €
• Endoscopic dacryocystorhi...
   Price 5.50 €
• Case report on a nasal gl...
   Price 5.50 €
• Immunohistochemistry expr...
   Price 10.50 €

Total Order 332.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE